世界の組織シーラントおよび組織接着剤市場は、今後数年間（2021〜2031）に8%のCAGRで成長し、2021年の22億ドルから2031年までに46億ドルを超える見込みです。市場の推進要因には、美容手術、腹腔鏡手術、心臓手術の増加；外科的処置を必要とするさまざまな種類の癌の増加；および多数の大手企業による新しい手術器具の開発などがあります。さらに、整形外科の問題の有病率が高まるにつれて、外科的損傷を軽減するための外科用シーラントおよび接着剤の需要も増加しており、これが市場の拡大を促進すると予想されます。
目次
1 Executive Summary
2 Global Tissue Sealants and Tissue Adhesive Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 Average Pricing Analysis
5 Macro-Economic Indicators
6 Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8 Recent Development, Policies & Regulatory Landscape
9 Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 Global Tissue Sealants and Tissue Adhesive Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 Global Tissue Sealants and Tissue Adhesive Market
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 Global Tissue Sealants and Tissue Adhesive Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Mexico, Brazil, and Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (United Kingdom, France, Germany, Italy, Spain, Switzerland, and Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (India, China, South Korea, Japan, and Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (North Africa, South Africa, and Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Type: Market Share (2020-2031F)
12.2.1. Natural Biological Sealants & Adhesives, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Synthetic and Semi-Synthetic Sealants & Adhesives, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Indication: Market Share (2020-2031F)
12.3.1. Tissue Sealing & Hemostasis, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Tissue Engineering, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 Company Profile
13.1. Baxter International, Inc.
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. CryoLife, Inc.
13.3. C.R. Bard, Inc.
13.4. Medtronic PLC
13.5. B. Braun Melsungen AG
13.6. Cohera Medical, Inc.
13.7. Ethicon, Inc. [J&J]
13.8. Mallinckrodt plc
13.9. Cardinal Health
13.10. Integra LifeSciences
13.11. Other Prominent Players
14 Consultant Recommendation
The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
